Literature DB >> 24232696

Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study.

Masaru Suzuki1, Hironi Makita, Yoichi M Ito, Katsura Nagai, Satoshi Konno, Masaharu Nishimura.   

Abstract

Exacerbations are among the major factors that may affect the natural history of chronic obstructive pulmonary disease (COPD). The aim was to investigate the clinical characteristics and determinants of COPD exacerbations in our 5-year observational cohort study which had a very low exacerbation frequency. A total of 279 patients with COPD participated in the Hokkaido COPD cohort study, and 268 subjects who had clinical data for multiple visits were analysed. Exacerbation was defined in multiple ways: the patient's subjective complaint, symptom definition, requiring prescription change, requiring antibiotic treatment, or requiring hospital admission. Exacerbation frequency (events per person per year) was 0.78 ± 1.16, 0.24 ± 0.47, 0.20 ± 0.43, 0.13 ± 0.28 and 0.06 ± 0.19 for subjective complaint and symptom, prescription, antibiotic and hospital admission definitions, respectively. Exacerbation events did not significantly affect the annual decline in forced expiratory volume in 1 s. A high St George's Respiratory Questionnaire total score, especially activity score, and a low body mass index were strongly associated with exacerbation-free survival, exacerbation frequency and development of recurrent exacerbations. Despite the low exacerbation frequency in our cohort, impaired health-related quality of life and weight loss were found to be independent risk factors for COPD exacerbations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24232696     DOI: 10.1183/09031936.00110213

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  40 in total

1.  Risk Factors for Pneumonia and the Effect of the Pneumococcal Vaccine in Patients With Chronic Airflow Obstruction.

Authors:  Kazuyoshi Kurashima; Yotaro Takaku; Keitaro Nakamoto; Tetsu Kanauchi; Noboru Takayanagi; Tsutomu Yanagisawa; Yutaka Sugita; Ryuichiro Araki
Journal:  Chronic Obstr Pulm Dis       Date:  2016-06-01

2.  Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.

Authors:  Mark T Dransfield; Ken M Kunisaki; Matthew J Strand; Antonio Anzueto; Surya P Bhatt; Russell P Bowler; Gerard J Criner; Jeffrey L Curtis; Nicola A Hanania; Hrudaya Nath; Nirupama Putcha; Sarah E Roark; Emily S Wan; George R Washko; J Michael Wells; Christine H Wendt; Barry J Make
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

3.  Machine Learning Prediction of Progression in Forced Expiratory Volume in 1 Second in the COPDGene® Study.

Authors:  Adel Boueiz; Zhonghui Xu; Yale Chang; Aria Masoomi; Andrew Gregory; Sharon M Lutz; Dandi Qiao; James D Crapo; Jennifer G Dy; Edwin K Silverman; Peter J Castaldi
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

4.  Characterization and Triggers of Dyspnea in Patients with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure: Effects of Weather and Environment.

Authors:  Ayham Daher; Michael Matthes; András Keszei; Vincent Brandenburg; Tobias Müller; Christian Cornelissen; Michael Dreher
Journal:  Lung       Date:  2018-10-10       Impact factor: 2.584

5.  One-year clinically important deterioration and long-term clinical course in Japanese patients with COPD: a multicenter observational cohort study.

Authors:  Yuki Abe; Masaru Suzuki; Hironi Makita; Hirokazu Kimura; Kaoruko Shimizu; Satoshi Konno; Masaharu Nishimura
Journal:  BMC Pulm Med       Date:  2021-05-12       Impact factor: 3.317

Review 6.  Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan.

Authors:  Nobuyuki Horita; Takeshi Kaneko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-04-21

7.  The reasons for triple therapy in stable COPD patients in Japanese clinical practice.

Authors:  Masaki Miyazaki; Hidetoshi Nakamura; Saeko Takahashi; Shotaro Chubachi; Mamoru Sasaki; Mizuha Haraguchi; Hideki Terai; Makoto Ishii; Koichi Fukunaga; Sadatomo Tasaka; Kenzo Soejima; Koichiro Asano; Tomoko Betsuyaku
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-04

8.  Phenotype and management of chronic obstructive pulmonary disease patients in general population in China: a nationally cross-sectional study.

Authors:  Heling Bao; Guohua Jia; Shu Cong; Wanlu Sun; Jing Fan; Ning Wang; Yajing Feng; Baohua Wang; Jeffrey L Curtis; Linhong Wang; Liwen Fang; Yahong Chen
Journal:  NPJ Prim Care Respir Med       Date:  2021-06-01       Impact factor: 2.871

9.  Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysis.

Authors:  Shigeo Muro; Masaru Suzuki; Shuhei Nakamura; Jocelyn Ruoyi Wang; Elizabeth M Garry; Wataru Sakamoto; Sabrina de Souza
Journal:  Respir Res       Date:  2021-06-17

10.  Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients.

Authors:  Katsura Nagai; Hironi Makita; Masaru Suzuki; Kaoruko Shimizu; Satoshi Konno; Yoichi M Ito; Masaharu Nishimura
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.